{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:04:17Z","timestamp":1778403857560,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["003382Q122"],"award-info":[{"award-number":["003382Q122"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007928","name":"Perelman School of Medicine, University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001878"],"award-info":[{"award-number":["UL1TR001878"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009993","name":"Center for Clinical and Translational Research","doi-asserted-by":"publisher","award":["UL1RR024134"],"award-info":[{"award-number":["UL1RR024134"]}],"id":[{"id":"10.13039\/100009993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009993","name":"Center for Clinical and Translational Research","doi-asserted-by":"publisher","award":["UL1TR000003"],"award-info":[{"award-number":["UL1TR000003"]}],"id":[{"id":"10.13039\/100009993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jcf.2023.09.010","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:55:59Z","timestamp":1696834559000},"page":"481-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-7355","authenticated-orcid":false,"given":"Rosara","family":"Bass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceylan","family":"Tanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3472-5934","authenticated-orcid":false,"given":"Kyle","family":"Bittinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhe","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot S\uff0e","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imhoi","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-0070","authenticated-orcid":false,"given":"Andrew D\uff0e","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D\uff0e","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia A\uff0e","family":"Stallings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2023.09.010_bib0001","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0039-1696726","article-title":"Growth and nutrition in cystic fibrosis","volume":"40","author":"Brownell","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.010_bib0002","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in cystic fibrosis","volume":"16","author":"Singh","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2023.09.010_bib0003","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3476(82)80501-5","article-title":"Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption","volume":"100","author":"Gaskin","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.09.010_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/948367","article-title":"Update of faecal markers of inflammation in children with cystic fibrosis","volume":"2012","author":"Lee","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"18","key":"10.1016\/j.jcf.2023.09.010_bib0005","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2023.09.010_bib0006","series-title":"Vertex pharmaceuticals incorporated","year":"2020"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.010_bib0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.jcf.2023.09.010_bib0008","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.010_bib0009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.09.010_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.09.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.111124","volume":"85","author":"King","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.jcf.2023.09.010_bib0012","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep [Internet]"},{"key":"10.1016\/j.jcf.2023.09.010_bib0013","first-page":"99","article-title":"Restoration of exocrine pancreatic function in older children with cystic fibrosis on ivacaftor","volume":"35","author":"Nichols","year":"2020","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0014","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/ctg.2017.10","article-title":"Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation","volume":"8","author":"Gelfond","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jcf.2023.09.010_bib0015","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/nu13092907","article-title":"The impact of highly effective CFTR modulators on growth and nutrition status","volume":"13","author":"Bass","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.010_bib0016","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcf.2018.09.001","article-title":"IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation","volume":"18","author":"van de Peppel","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.010_bib0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcf.2015.01.006","volume":"14","author":"Bodewes","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"24","key":"10.1016\/j.jcf.2023.09.010_bib0018","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0019","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5056\/jnm20149","article-title":"Gut microbial dysbiosis in the pathogenesis of gastrointestinal dysmotility and metabolic disorders","volume":"27","author":"Singh","year":"2021","journal-title":"J Neurogastroenterol Motil"},{"issue":"8","key":"10.1016\/j.jcf.2023.09.010_bib0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrgastro.2015.114","article-title":"The promise of metabolic phenotyping in gastroenterology and hepatology","volume":"12","author":"Holmes","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0021","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaci.2019.10.014","article-title":"Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma","volume":"145","author":"Crestani","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcf.2023.09.010_bib0022","doi-asserted-by":"crossref","first-page":"24857","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2023.09.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.06.002","article-title":"Modulation, microbiota and inflammation in the adult CF gut: a prospective study","author":"Ronan","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"7415","key":"10.1016\/j.jcf.2023.09.010_bib0024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jcf.2023.09.010_bib0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/gutjnl-2020-323476","article-title":"Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.767","article-title":"Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin","volume":"8","author":"Patti","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"7341","key":"10.1016\/j.jcf.2023.09.010_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"7231","key":"10.1016\/j.jcf.2023.09.010_bib0028","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1203\/PDR.0b013e3181df4ea0","article-title":"Metabolomics of volatile organic compounds in cystic fibrosis patients and controls","volume":"68","author":"Robroeks","year":"2010","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.jcf.2023.09.010_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ppul.22859","article-title":"Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis","volume":"49","author":"Joseloff","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0031","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.freeradbiomed.2012.05.001","article-title":"Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients","volume":"53","author":"Yang","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jcf.2023.09.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106687","article-title":"Sweat metabolomics before and after intravenous antibiotics for pulmonary exacerbation in people with cystic fibrosis","volume":"191","author":"Woodley","year":"2022","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.jcf.2023.09.010_bib0033","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jcf.2019.12.007","article-title":"Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity","volume":"19","author":"Sagel","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"20","key":"10.1016\/j.jcf.2023.09.010_bib0034","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.3390\/ijms232012436","article-title":"Elevated levels of toxic bile acids in serum of cystic fibrosis patients with CFTR mutations causing pancreatic insufficiency","volume":"23","author":"Tabori","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12866-021-02305-z","article-title":"Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences","volume":"21","author":"Eng","year":"2021","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0036","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2023.09.010_bib0037","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/s41598-017-06880-y","article-title":"A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis","volume":"7","author":"Fouhy","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jcf.2023.09.010_bib0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.gene.2014.10.039","article-title":"Lipidomics in the study of lipid metabolism: current perspectives in the omic sciences","volume":"554","author":"Rolim","year":"2015","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.jcf.2023.09.010_bib0039","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/ped.13063","article-title":"Is there a role for stool metabolomics in cystic fibrosis?","volume":"58","author":"Kaakoush","year":"2016","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.jcf.2023.09.010_bib0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ppul.23972","article-title":"Metabolomic responses to lumacaftor\/ivacaftor in cystic fibrosis","volume":"53","author":"Kopp","year":"2018","journal-title":"Pediatr. Pulmonol."},{"issue":"9","key":"10.1016\/j.jcf.2023.09.010_bib0041","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ppul.23225","article-title":"Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation","volume":"50","author":"Laguna","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.09.010_bib0042","article-title":"CFTR correctors and antioxidants partially normalize lipid imbalance but not abnormal basal inflammatory cytokine profile in CF bronchial epithelial cells","volume":"12","author":"Veltman","year":"2021","journal-title":"Front Physiol [Internet]"},{"key":"10.1016\/j.jcf.2023.09.010_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105622","article-title":"Inflammatory role of extracellular sphingolipids in Cystic Fibrosis","volume":"116","author":"Zulueta","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0044","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcf.2018.06.004","article-title":"Italian and North American dietary intake after ivacaftor treatment for cystic fibrosis gating mutations","volume":"18","author":"Sainath","year":"2019","journal-title":"J Cystic Fibrosis"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chom.2020.12.012","article-title":"Role of dietary fiber in the recovery of the human gut microbiome and its metabolome","volume":"29","author":"Tanes","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0046","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.chom.2020.07.020","article-title":"Multi-omic analysis of the interaction between Clostridioides difficile infection and pediatric inflammatory bowel disease","volume":"28","author":"Bushman","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.jcf.2023.09.010_bib0047","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0048","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40168-019-0658-x","article-title":"Sunbeam: an extensible pipeline for analyzing metagenomic sequencing experiments","volume":"7","author":"Clarke","year":"2019","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0049","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/gb-2014-15-3-r46","article-title":"Kraken: ultrafast metagenomic sequence classification using exact alignments","volume":"15","author":"Wood","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.jcf.2023.09.010_bib0051","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2307\/1934145","article-title":"The nonconcept of species diversity: a critique and alternative parameters","volume":"52","author":"Hurlbert","year":"1971","journal-title":"Ecology"},{"key":"10.1016\/j.jcf.2023.09.010_bib0052","unstructured":"An Ordination of the Upland Forest Communities of Southern Wisconsin - Bray - 1957 - Ecological Monographs - Wiley Online Library [Internet]. [cited 2022 Dec 13]. Available from: https:\/\/esajournals.onlinelibrary.wiley.com\/doi\/10.2307\/1942268."},{"issue":"8","key":"10.1016\/j.jcf.2023.09.010_bib0053","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nmeth.2551","article-title":"LipidBlast in silico tandem mass spectrometry database for lipid identification","volume":"10","author":"Kind","year":"2013","journal-title":"Nat Methods"},{"issue":"6","key":"10.1016\/j.jcf.2023.09.010_bib0054","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcf.2023.09.010_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-0716-0849-4_15","article-title":"Quantitative analysis of bile acid with UHPLC-MS\/MS","volume":"2194","author":"Tian","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcf.2023.09.010_bib0056","unstructured":"Anderson M.J. A new method for non-parametric multivariate analysis of variance."},{"key":"10.1016\/j.jcf.2023.09.010_bib0057","unstructured":"Controlling the false discovery rate: a practical and powerful approach to multiple testing - Benjamini - 1995 - Journal of the Royal Statistical Society: series B (Methodological) - Wiley Online Library [Internet]. [cited 2022 Dec 13]. Available from: https:\/\/rss.onlinelibrary.wiley.com\/doi\/10.1111\/j.2517-6161.1995.tb02031.x."},{"issue":"7758","key":"10.1016\/j.jcf.2023.09.010_bib0058","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcf.2023.09.010_bib0059","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.plipres.2009.03.003","article-title":"Odd-numbered very-long-chain fatty acids from the microbial, animal and plant kingdoms","volume":"48","author":"\u0158ezanka","year":"2009","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.jcf.2023.09.010_bib0061","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcf.2018.08.009","article-title":"Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis","volume":"18","author":"van de Peppel","year":"2019","journal-title":"J Cystic Fibrosis"},{"issue":"5","key":"10.1016\/j.jcf.2023.09.010_bib0062","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jcf.2020.12.002","article-title":"Changes in fecal microbiota with CFTR modulator therapy: a pilot study","volume":"20","author":"Pope","year":"2021","journal-title":"J Cystic Fibrosis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323009153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323009153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:31:06Z","timestamp":1777649466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323009153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1569199323009153"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.09.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}